NCT00047242View on ClinicalTrials.gov

UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

February 28, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

7-hydroxystaurosporine

DRUG

irinotecan hydrochloride

Trial Locations (1)

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00047242 - UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter